ORBIMED ADVISORS LLC 13D/13G Filings for ADC Therapeutics SA (ADCT)

ORBIMED ADVISORS LLC 13D and 13G filings for ADC Therapeutics SA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:35 pm
Purchase
2024-12-31 13G ADC Therapeutics SA
ADCT
ORBIMED ADVISORS LLC 3,437,813
3.600%
3,437,813increase
(New Position)
Filing